A student-run resource for reliable reports on the latest law and technology news

Archive for the ‘Patent’ Category

Federal Circuit Penalizes ICU Medical, Inc. and Counsel Paul Hastings for Frivolous Patent Infringement Suit By Jamie Wicks – Edited by Joshua Gruenspecht ICU Medical, Inc. v. Alaris Medical Systems, Inc. Federal Circuit, March 13, 2009, No. 2008-1077 Opinion On March 13th, the Federal Circuit unanimously affirmed the United States District Court for the Central District of California, which had granted summary judgment in favor of Alaris in a suit in which ICU claimed infringement of its patents for spiked ... Read More...
Posted On Mar - 28 - 2009 Comments Off READ FULL POST
By Sarah Sorscher*, JD/MPH Candidate, Harvard Law School & Sara Crager, MD/PhD Candidate, Yale Editorial Policy Text of H.R. 1427 Summary Last week, Rep. Henry Waxman and several other representatives unveiled the latest version of a bill designed to lower the price of drugs by encouraging generic competition in biological products (“biologics”). Biologics are products derived from living processes and used to prevent, treat, or cure human illness. Most drugs, in contrast, are synthesized using chemical reactions.  Biologics include products such as vaccines, blood-derived products, antibodies, ... Read More...
Posted On Mar - 19 - 2009 Comments Off READ FULL POST
In re Bilski Redefined? By Briahna Gray – Edited by Anthony Kammer In re Lewis Ferguson, Darryl Costin and Scott C. Harris Federal Circuit, March 6, 2009, Serial No. 09/387,823 Order On March 6, 2009, the Federal Circuit Court of Appeals upheld a ruling by the Board of Patent Appeals and Interferences that a marketing paradigm for multiple independent software companies fashioned by Lewis Ferguson, Darryl Costin, and Scott C. Harris was not patentable under the U.S. Patent Act, 35 ... Read More...
Posted On Mar - 15 - 2009 Comments Off READ FULL POST
Eli Lilly Granted Stay Extension, Prevents Teva’s Generic Alternative Until March 9th By Brian Kozlowski – Edited by Anna Lamut Eli Lilly & Co. v. Teva Pharma Federal Circuit, February 24, 2009, No. 2009-1071 Opinion On February 24th, the Federal Circuit affirmed two to one an order by the United States District Court for the Southern District of Indiana extending the 30-month statutory stay on FDA approval of Teva Pharmaceuticals‘ generic version of Eli Lilly‘s postmenopausal osteoporosis drug, Evista®. The ... Read More...
Posted On Mar - 2 - 2009 Comments Off READ FULL POST
Federal Circuit, in a 2-1 Decision, Affirms Nonobviousness Determination in Medical Supply Case; Split Highlights Difficulty of Claim Construction By Chris Kulawik –- Edited by Stephanie Weiner Kinetic Concepts, Inc. v. Blue Sky Medical Group, Inc. Federal Circuit, February 2, 2009, Nos. 07-1340, 07-1341, & 07-1342 Slip Opinion In a 2-1 split, the Federal Circuit affirmed a nonobviousness determination in a contentious dispute between medical technology companies. The case turned on the construction of the claim term “treating a wound” ... Read More...
Posted On Feb - 8 - 2009 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
  • GooglePlay
Icon-news

Federal Circuit Flas

By Steven Wilfong Multimedia car system patents ruled as unenforceable based ...

Icon-news

Flash Digest: News i

By Viviana Ruiz Converse attempts to protect iconic Chuck Taylor All ...

silkroad_fbi_110813

Silk Road Founder Lo

By Travis West — Edited by Mengyi Wang Order, United States ...

free-speech

Trademark Infringeme

By Yunnan Jiang – Edited by Paulius Jurcys Brief for the ...

Twitter.png?t=20130219104123

Twitter goes to cour

By Jens Frankenreiter – Edited by Michael Shammas Twitter, Inc. vs. ...